Thomas P. O'Neil, Chief Financial Officer at Protagonist Therapeutics, Inc (PTGX), sold 8,000 shares at $20.00 ($160K) on 2017-12-18, disclosed to the SEC on 2017-12-20.
Open-market sale of $160k PTGX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| STSA | SELL | 2020-07-02 | $27K | — | Filing → |
| STSA | SELL | 2020-06-24 | $149K | — | Filing → |
| STSA | SELL | 2020-06-02 | $25K | — | Filing → |